VIREN MEHTA Insider Trading $OSIP OSI PHARMACEUTICALS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for VIREN MEHTA.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of VIREN MEHTA. VIREN MEHTA is Director in OSI PHARMACEUTICALS INC ($OSIP) and Director in Onconova Therapeutics, Inc. ($ONTX).
VIREN MEHTA in OSI PHARMACEUTICALS INC
Trading Symbol: OSIPIndustry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of VIREN MEHTA: Director
Holdings: 77,754 shares
Latest Transaction: Oct 24 2005
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of VIREN MEHTA in OSI PHARMACEUTICALS INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 24 2005 | OSIP | OSI PHARMACEUTICAL ... | MEHTA VIREN | Director | Option Exercise | M | 15.02 | 17,231 | 258,810 | 2,769 | |
Oct 24 2005 | OSIP | OSI PHARMACEUTICAL ... | MEHTA VIREN | Director | Option Exercise | M | 5.38 | 50,000 | 268,750 | 0 | |
Oct 24 2005 | OSIP | OSI PHARMACEUTICAL ... | MEHTA VIREN | Director | Buy | M | 15.02 | 17,231 | 258,810 | 77,754 | 60.5 K to 77.8 K (+28.47 %) |
Oct 24 2005 | OSIP | OSI PHARMACEUTICAL ... | MEHTA VIREN | Director | Buy | M | 5.38 | 50,000 | 268,750 | 60,523 | 10.5 K to 60.5 K (+475.15 %) |
Oct 24 2005 | OSIP | OSI PHARMACEUTICAL ... | MEHTA VIREN | Director | Grant | A | 21.99 | 3,000 | 65,970 | 10,523 | 7.5 K to 10.5 K (+39.88 %) |
Mar 18 2005 | OSIP | OSI PHARMACEUTICAL ... | MEHTA VIREN | Director | Option Exercise | A | 45.60 | 15,000 | 684,000 | 15,000 | |
Mar 18 2005 | OSIP | OSI PHARMACEUTICAL ... | MEHTA VIREN | Director | Grant | A | 45.60 | 1,371 | 62,518 | 7,523 | 6.2 K to 7.5 K (+22.29 %) |
Sep 17 2004 | OSIP | OSI PHARMACEUTICAL ... | MEHTA VIREN | Director | Sell | S | 62.48 | 3,400 | 212,432 | 6,152 | 9.6 K to 6.2 K (-35.59 %) |
Sep 17 2004 | OSIP | OSI PHARMACEUTICAL ... | MEHTA VIREN | Director | Sell | S | 62.43 | 1,200 | 74,916 | 9,552 | 10.8 K to 9.6 K (-11.16 %) |
Sep 17 2004 | OSIP | OSI PHARMACEUTICAL ... | MEHTA VIREN | Director | Sell | S | 62.42 | 900 | 56,178 | 10,752 | 11.7 K to 10.8 K (-7.72 %) |
Sep 17 2004 | OSIP | OSI PHARMACEUTICAL ... | MEHTA VIREN | Director | Sell | S | 62.41 | 600 | 37,446 | 11,652 | 12.3 K to 11.7 K (-4.90 %) |
Sep 17 2004 | OSIP | OSI PHARMACEUTICAL ... | MEHTA VIREN | Director | Sell | S | 62.40 | 2,000 | 124,800 | 12,252 | 14.3 K to 12.3 K (-14.03 %) |
Sep 17 2004 | OSIP | OSI PHARMACEUTICAL ... | MEHTA VIREN | Director | Sell | S | 62.35 | 1,100 | 68,585 | 14,252 | 15.4 K to 14.3 K (-7.17 %) |
Sep 17 2004 | OSIP | OSI PHARMACEUTICAL ... | MEHTA VIREN | Director | Sell | S | 62.29 | 600 | 37,374 | 15,352 | 16 K to 15.4 K (-3.76 %) |
Sep 17 2004 | OSIP | OSI PHARMACEUTICAL ... | MEHTA VIREN | Director | Sell | S | 62.26 | 100 | 6,226 | 15,952 | 16.1 K to 16 K (-0.62 %) |
Sep 17 2004 | OSIP | OSI PHARMACEUTICAL ... | MEHTA VIREN | Director | Sell | S | 62.25 | 10,600 | 659,850 | 16,052 | 26.7 K to 16.1 K (-39.77 %) |
Sep 17 2004 | OSIP | OSI PHARMACEUTICAL ... | MEHTA VIREN | Director | Sell | S | 62.10 | 4,200 | 260,820 | 26,652 | 30.9 K to 26.7 K (-13.61 %) |
Sep 17 2004 | OSIP | OSI PHARMACEUTICAL ... | MEHTA VIREN | Director | Sell | S | 62.01 | 300 | 18,603 | 30,852 | 31.2 K to 30.9 K (-0.96 %) |
Sep 17 2004 | OSIP | OSI PHARMACEUTICAL ... | MEHTA VIREN | Director | Sell | S | 62.00 | 5,000 | 310,000 | 31,152 | 36.2 K to 31.2 K (-13.83 %) |
Mar 19 2004 | OSIP | OSI PHARMACEUTICAL ... | MEHTA VIREN | Director | Option Exercise | A | 38.61 | 15,000 | 579,150 | 15,000 | |
Mar 19 2004 | OSIP | OSI PHARMACEUTICAL ... | MEHTA VIREN | Director | Grant | A | 0.00 | 1,619 | 0 | 36,152 | 34.5 K to 36.2 K (+4.69 %) |
Page: 1